Document Detail


Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity.
MedLine Citation:
PMID:  20190967     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
For many years the neuromodulator adenosine has been recognized as an endogenous anticonvulsant molecule and termed a "retaliatory metabolite." As the core molecule of ATP, adenosine forms a unique link between cell energy and neuronal excitability. In parallel, a ketogenic (high-fat, low-carbohydrate) diet is a metabolic therapy that influences neuronal activity significantly, and ketogenic diets have been used successfully to treat medically-refractory epilepsy, particularly in children, for decades. To date the key neural mechanisms underlying the success of dietary therapy are unclear, hindering development of analogous pharmacological solutions. Similarly, adenosine receptor-based therapies for epilepsy and myriad other disorders remain elusive. In this review we explore the physiological regulation of adenosine as an anticonvulsant strategy and suggest a critical role for adenosine in the success of ketogenic diet therapy for epilepsy. While the current focus is on the regulation of adenosine, ketogenic metabolism and epilepsy, the therapeutic implications extend to acute and chronic neurological disorders as diverse as brain injury, inflammatory and neuropathic pain, autism and hyperdopaminergic disorders. Emerging evidence for broad clinical relevance of the metabolic regulation of adenosine will be discussed.
Authors:
S A Masino; M Kawamura; C D Wasser; C A Wasser; L T Pomeroy; D N Ruskin
Related Documents :
19220407 - Ketogenic diet in the treatment of refractory continuous spikes and waves during slow s...
17332207 - The ketogenic diet: one decade later.
1171497 - Levels of pyridoxine and susceptibility to electroconvulsive and audiogenic seizures.
19049597 - Acetone as an anticonvulsant.
16415657 - Postprandial lipemia in postmenopausal women with high fasting high-density lipoprotein...
9049447 - Higher high density lipoprotein cholesterol associated with moderate alcohol consumptio...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current neuropharmacology     Volume:  7     ISSN:  1875-6190     ISO Abbreviation:  Curr Neuropharmacol     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2010-03-01     Completed Date:  2010-06-18     Revised Date:  2011-06-06    
Medline Journal Info:
Nlm Unique ID:  101157239     Medline TA:  Curr Neuropharmacol     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  257-68     Citation Subset:  -    
Affiliation:
Psychology Department, Trinity College, 300 Summit St., Hartford, CT, USA. susan.masino@trincoll.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections
Erratum In:
Curr Neuropharmacol. 2010 Mar;8(1):81
Note: Wasser, C A [corrected to Wasser, C D]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adenosine and the auditory system.
Next Document:  Tularemia, plague, yersiniosis, and Tyzzer's disease in wild rodents and lagomorphs in Canada: A rev...